NCT03833167 2026-03-10
KEYNOTE-630
Merck Sharp & Dohme LLC
Phase 3 Completed
Clinical Trials
83 trialsNCT04150900 2026-02-19
1922GCCC: Pembro and Bavituximab for Squamous Cell Carcinoma of Head and Neck
University of Maryland, Baltimore
Phase 2 Active not recruiting
NCT06669572 2026-02-17
Lenvatinib and Pembrolizumab to Treat Patients With Anal or Rectum Cancer That Has Gotten Worse After Initial Treatment
University of Chicago
Phase 2 Recruiting
NCT07384949 2026-02-03
SCC-DERM
Istanbul Training and Research Hospital
Not yet recruiting
NCT07346196 2026-01-20
A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck
University of Chicago
Phase 2 Not yet recruiting
NCT07311057 2026-01-06
Investigation of Effect of Formulated Methylene Blue on Treatment of Squamous Cell Carcinoma Skin Cancer in Inoperable Patients and Not Suitable for Radiotherapy
Mashhad University of Medical Sciences
Phase 3 Enrolling by invitation
NCT02131805 2025-12-30
Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell Carcinoma
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT05027633 2025-11-19
Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA)
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT06762808 2025-08-15
Phase II Study of Atezolizumab and Tiragolumab With ctDNA for HPV-positive SCC
M.D. Anderson Cancer Center
Phase 2 Withdrawn
NCT03370406 2025-06-15
Intralesional 5-Fluorouracil (5FU), Topical Calcipotriene Treatment for SCC
University of Pittsburgh
Phase 1 Recruiting
NCT05108090 2025-06-11
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
Indiana University
Phase NA Recruiting
NCT04808999 2025-05-29
Neoadjuvant Study of PD-1 Inhibitor Pembrolizumab in PD-1 Naive Cutaneous Squamous Cell Carcinoma (cSCC)
University of Pittsburgh
Phase 2 Active not recruiting
NCT04224389 2025-05-08
TORPHYNX
Gustave Roussy, Cancer Campus, Grand Paris
Recruiting
NCT06731933 2025-04-16
Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin
Stanford University
Phase 2 Recruiting
NCT04050436 2025-01-27
CERPASS
Replimune Inc.
Phase 2 Active not recruiting
NCT06782399 2025-01-17
SCC
Brigham and Women's Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT03719924 2025-01-08
OESIRI
Federation Francophone de Cancerologie Digestive
Phase 2 Completed
NCT04685798 2024-09-19
Optimized Diffusion-Weighted Imaging for the Evaluation of Post-Treatment Squamous Cell Carcinoma in the Neck: Comparative Study With FDG PET/CT
Washington University School of Medicine
Phase NA Terminated
NCT01706939 2024-08-29
The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer
Icahn School of Medicine at Mount Sinai
Phase 3 Active not recruiting
NCT06377735 2024-08-09
BAI-BACE for Advanced Lung Squamous Cell Carcinoma
Sun Yat-sen University
Phase NA Recruiting
NCT01581840 2024-07-01
Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus
Federation Francophone de Cancerologie Digestive
Phase 1/2 Completed
NCT03292822 2024-06-20
Effects of (Licochalcone A) and Paclitaxel on Human Oral Squamous Cell Carcinoma Cell Line
Cairo University
Phase 1 Completed
NCT06450080 2024-06-10
ClimaBio
Centre Hospitalier Universitaire, Amiens
Phase NA Recruiting
NCT05841966 2024-05-07
OP-CUP
Rigshospitalet, Denmark
Phase NA Completed
NCT02551458 2024-03-07
Esostrate
Centre Hospitalier Universitaire Dijon
Phase 2/3 Terminated
NCT01755650 2023-09-13
Phase 0 of 18F FPM Using PET/CT in Patients With a Variety of Malignancies
Peter MacCallum Cancer Centre, Australia
Phase EARLY_PHASE1 Terminated
NCT05729139 2023-08-09
Cemiplimab/Peg-Interferon-α in Advanced CSCC
Baptist Health South Florida
Phase 1 Withdrawn
NCT05929547 2023-07-03
Patient Perspectives in Squamous Cell Carcinoma Clinical Trials
Power Life Sciences Inc.
Not yet recruiting
NCT05852665 2023-05-10
BRUG
UMC Utrecht
Phase NA Unknown
NCT05019235 2023-03-07
MACARAN
Fondation Hôpital Saint-Joseph
Unknown
NCT04839731 2023-02-13
Combination 5-FU / Calcipotriene Cream for SCCIS/SCC
Carilion Clinic
Phase EARLY_PHASE1 Unknown
NCT02213133 2023-01-26
STARRS
Karyopharm Therapeutics Inc
Phase 2 Terminated
NCT05611515 2022-11-10
SUPRA-QoL
Centre Hospitalier Universitaire UCLouvain Namur
Recruiting
NCT05552807 2022-09-23
SCT200 in Combination With SCT-I10A/Paclitaxel/Docetaxel in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Sinocelltech Ltd.
Phase 1 Unknown
NCT01220752 2022-09-01
IMRT-HIT-SNT
Heidelberg University
Phase 2 Completed
NCT02426879 2021-09-30
Node
UMC Utrecht
Phase NA Completed
NCT03875859 2021-05-20
Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC)
Stanford University
Phase 2 Terminated
NCT02883556 2021-01-13
CARSKIN
Assistance Publique - Hôpitaux de Paris
Phase 2 Completed
NCT04533321 2020-08-31
A Biomarker-implemented Clinical Study Evaluating Mutations in MET and TP53 in a Population of Treatment-refractory Squamous Cell Carcinoma
National University Hospital, Singapore
Phase 2 Unknown
NCT01976468 2019-07-29
Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study"
University of Zurich
Unknown
NCT00389727 2019-07-15
Simultaneous Integrated Boost (SIB)- IMRT
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Phase 2 Completed
NCT03652233 2019-06-20
Afatinib and Nivolumab as Treatment for Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
Vanderbilt-Ingram Cancer Center
Phase 1 Withdrawn
NCT00507702 2019-04-18
Identification of Key Blood Molecular Markers for Immunotherapy
Stanford University
Terminated
NCT00652080 2019-03-05
An Open-Label Safety Study of API 31510 in a Topical Cream for in Situ Cutaneous Squamous Cell Carcinoma (SCCIS)
BPGbio
Phase 1/2 Completed
NCT00534950 2019-03-01
Randomized Multicenter Study of 5 vs 6 Weekly Fraction of RT in the Treatment of SCC of the Head and Neck
King Faisal Specialist Hospital & Research Center
Phase NA Completed
NCT03830710 2019-02-20
8-Hydroxy-2-Deoxyguanosine ,Total Antioxidant Capacity in Oral Premalignant and Malignant Lesions
Fayoum University
Completed
NCT03837613 2019-02-12
Prognostic Value of Tumor Thickness of Buccal Mucosa Squamous Cell Carcinoma on the Incidence of Nodal Metastasis.
Cairo University
Unknown
NCT02269020 2019-01-11
RoboCurage ORL
Centre Hospitalier Universitaire de Nīmes
Phase 1 Completed
NCT02241369 2018-11-16
Immunotherapy in Subjects With HPV-6 Associated Aerodigestive Precancerous Lesions and Malignancies
Inovio Pharmaceuticals
Phase 1 Completed
NCT03636685 2018-08-17
Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC
ChineseAMS
Phase 1/2 Unknown